Therma Bright

Therma Bright Inc. is a publicly traded company (TSVX: THRM) that serves the $21 billion cosmeceutical industry. Therma Bright Inc. has patents and trademarks pending for its Therozap™ and InterceptCS™ brands, as well as regulatory approval for its breakthrough heat therapy technology. The company’s technology uses thermal and light energy to provide effective, pain-free topical skincare.Therma Bright Inc. has made significant investments in intellectual property and R&D for its InterceptCS™ cold sore device and Therozap™ insect bite device, and will soon invest in a new pain relief device. Therma’s current product line focuses on the treatment and prevention of cold sores, as well as the treatment of pain, itching, and inflammation associated with mosquito, bee, spider, mite, and jellyfish bites or stings. Therma Bright is in the R&D phase of developing a novel device aimed at alleviating pain related to back, knee, or other joint pain. Therma Bright is committed to building recurring revenue streams through its products and integrating smart technologies such as AI or IoT.The company’s current focus is on selling its products online through various social media networks and eventually establishing relationships with major retailers across North America and globally.